Omnicell
Omnicell Inc is an American healthcare technology company providing automated pharmacy management and medication dispensing solutions. The company manufactures automated dispensing cabinets, robotic pharmacy packaging systems, central pharmacy intelligence software, and medication adherence supplies. Principal revenues derive from hardware equipment sales, recurring software subscriptions, consumables supply, and long-term maintenance service agreements. Core end markets encompass acute care hospitals, health system networks, retail pharmacies, and long-term care facilities across North America and internationally. Omnicell holds a market-leading position in automated medication management and central pharmacy robotics in the United States. The corporation is headquartered in Fort Worth, Texas, and its common stock trades on the Nasdaq Global Select Market.
5 of the funds FundTelligence covers report a position in Omnicell.
- Legal name
- Omnicell Inc
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 5
Funds holding Omnicell
- Nordea BetaPlus Enhanced Global Sustainable Small Cap — Nordea Funds · 0.19 % (full portfolio disclosed, September 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.02 % (partially disclosed portfolio, June 2026)
- Nordea Internationale aktier — Nordea Funds · 0.01 % (full portfolio disclosed, September 2026)
- DNB Global Enhanced Small Cap — DNB · 0.01 % (full portfolio disclosed, September 2026)